Skip to main content
Premium Trial:

Request an Annual Quote

Brazilian Health Regulatory Agency Approves Premaitha's Noninvasive Prenatal Test as IVD

NEW YORK (GenomeWeb) – Premaitha Health said today that the Brazilian Health Regulatory Agency (ANVISA) has approved its Iona noninvasive prenatal test as an in vitro diagnostic.

Last September, the agency had already granted the Iona test Brazilian Good Manufacturing Practice (B-GMP) approval, a requirement to register it with ANVISA.

Premaitha said it is now seeking commercial partners in Brazil to make the test available in the country.

"Commercializing the Iona test in this significant South American market is another key step in Premaitha's diversification and de-risking strategy," said Premaitha CEO Stephen Little in a statement. "Whilst the territory will not be immediately revenue generating, with over 3 million births per annum, we anticipate Brazil will become a major market for Premaitha and that it will in due course provide a springboard to other South and Central America regions."

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.